抗癌药物负载ZnO纳米粒子的光学带隙和晶体尺寸研究

Deepak Kumar, Samanwita Pal
{"title":"抗癌药物负载ZnO纳米粒子的光学带隙和晶体尺寸研究","authors":"Deepak Kumar, Samanwita Pal","doi":"10.1063/1.5122627","DOIUrl":null,"url":null,"abstract":"The present study aims at the development and characterization of zinc oxide (ZnO) nanoparticles as a carrier for various anti-cancerous drugs viz. 5-Fluorouracil (5-FU), Doxorubicin (DOX) and Daunorubicin (DNR). ZnO nanoparticles were prepared by standard precipitation method. The measurement of optical band gap using UV-Visible Diffuse Reflectance Spectroscopy (DRS) analysis reveals the lowering of ZnO band gap after the drug loading. Crystallite size of free and drug loaded ZnO nanoparticles were determined using X-ray Diffraction (XRD) analysis. The crystallite size of ZnO nanoparticles increases after the drug loading. Both the techniques confirm the adsorption of drug molecules on ZnO surface.The present study aims at the development and characterization of zinc oxide (ZnO) nanoparticles as a carrier for various anti-cancerous drugs viz. 5-Fluorouracil (5-FU), Doxorubicin (DOX) and Daunorubicin (DNR). ZnO nanoparticles were prepared by standard precipitation method. The measurement of optical band gap using UV-Visible Diffuse Reflectance Spectroscopy (DRS) analysis reveals the lowering of ZnO band gap after the drug loading. Crystallite size of free and drug loaded ZnO nanoparticles were determined using X-ray Diffraction (XRD) analysis. The crystallite size of ZnO nanoparticles increases after the drug loading. Both the techniques confirm the adsorption of drug molecules on ZnO surface.","PeriodicalId":7262,"journal":{"name":"ADVANCES IN BASIC SCIENCE (ICABS 2019)","volume":"4 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Optical band gap and crystallite size investigations of anticancer drug loaded ZnO nanoparticles\",\"authors\":\"Deepak Kumar, Samanwita Pal\",\"doi\":\"10.1063/1.5122627\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The present study aims at the development and characterization of zinc oxide (ZnO) nanoparticles as a carrier for various anti-cancerous drugs viz. 5-Fluorouracil (5-FU), Doxorubicin (DOX) and Daunorubicin (DNR). ZnO nanoparticles were prepared by standard precipitation method. The measurement of optical band gap using UV-Visible Diffuse Reflectance Spectroscopy (DRS) analysis reveals the lowering of ZnO band gap after the drug loading. Crystallite size of free and drug loaded ZnO nanoparticles were determined using X-ray Diffraction (XRD) analysis. The crystallite size of ZnO nanoparticles increases after the drug loading. Both the techniques confirm the adsorption of drug molecules on ZnO surface.The present study aims at the development and characterization of zinc oxide (ZnO) nanoparticles as a carrier for various anti-cancerous drugs viz. 5-Fluorouracil (5-FU), Doxorubicin (DOX) and Daunorubicin (DNR). ZnO nanoparticles were prepared by standard precipitation method. The measurement of optical band gap using UV-Visible Diffuse Reflectance Spectroscopy (DRS) analysis reveals the lowering of ZnO band gap after the drug loading. Crystallite size of free and drug loaded ZnO nanoparticles were determined using X-ray Diffraction (XRD) analysis. The crystallite size of ZnO nanoparticles increases after the drug loading. Both the techniques confirm the adsorption of drug molecules on ZnO surface.\",\"PeriodicalId\":7262,\"journal\":{\"name\":\"ADVANCES IN BASIC SCIENCE (ICABS 2019)\",\"volume\":\"4 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-08-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ADVANCES IN BASIC SCIENCE (ICABS 2019)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1063/1.5122627\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ADVANCES IN BASIC SCIENCE (ICABS 2019)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1063/1.5122627","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

摘要

本研究旨在开发和表征氧化锌纳米颗粒作为各种抗癌药物的载体,即5-氟尿嘧啶(5-FU),阿霉素(DOX)和柔红霉素(DNR)。采用标准沉淀法制备ZnO纳米颗粒。利用紫外-可见漫反射光谱(DRS)分析测量了ZnO的带隙,结果表明载药后ZnO的带隙减小。利用x射线衍射(XRD)分析了负载ZnO纳米粒子的晶粒尺寸。载药后ZnO纳米颗粒的晶粒尺寸增大。两种方法都证实了药物分子在ZnO表面的吸附。本研究旨在开发和表征氧化锌纳米颗粒作为各种抗癌药物的载体,即5-氟尿嘧啶(5-FU),阿霉素(DOX)和柔红霉素(DNR)。采用标准沉淀法制备ZnO纳米颗粒。利用紫外-可见漫反射光谱(DRS)分析测量了ZnO的带隙,结果表明载药后ZnO的带隙减小。利用x射线衍射(XRD)分析了负载ZnO纳米粒子的晶粒尺寸。载药后ZnO纳米颗粒的晶粒尺寸增大。两种方法都证实了药物分子在ZnO表面的吸附。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Optical band gap and crystallite size investigations of anticancer drug loaded ZnO nanoparticles
The present study aims at the development and characterization of zinc oxide (ZnO) nanoparticles as a carrier for various anti-cancerous drugs viz. 5-Fluorouracil (5-FU), Doxorubicin (DOX) and Daunorubicin (DNR). ZnO nanoparticles were prepared by standard precipitation method. The measurement of optical band gap using UV-Visible Diffuse Reflectance Spectroscopy (DRS) analysis reveals the lowering of ZnO band gap after the drug loading. Crystallite size of free and drug loaded ZnO nanoparticles were determined using X-ray Diffraction (XRD) analysis. The crystallite size of ZnO nanoparticles increases after the drug loading. Both the techniques confirm the adsorption of drug molecules on ZnO surface.The present study aims at the development and characterization of zinc oxide (ZnO) nanoparticles as a carrier for various anti-cancerous drugs viz. 5-Fluorouracil (5-FU), Doxorubicin (DOX) and Daunorubicin (DNR). ZnO nanoparticles were prepared by standard precipitation method. The measurement of optical band gap using UV-Visible Diffuse Reflectance Spectroscopy (DRS) analysis reveals the lowering of ZnO band gap after the drug loading. Crystallite size of free and drug loaded ZnO nanoparticles were determined using X-ray Diffraction (XRD) analysis. The crystallite size of ZnO nanoparticles increases after the drug loading. Both the techniques confirm the adsorption of drug molecules on ZnO surface.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信